Findings from a preliminary study suggest that a drug combination that is the gold standard of HIV treatment in the developed world can help patients in developing countries as well. The new study, published in the July issue of the journal AIDS, followed up on a trial of highly active antiretroviral therapy (HAART) in the African nation of Senegal.